Trial Profile
A Phase II, Randomized, Placebo-Controlled Trial of Regadenoson in Sickle Cell Anemia
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Mar 2014
Price :
$35
*
At a glance
- Drugs Regadenoson (Primary)
- Indications Sickle cell anaemia
- Focus Therapeutic Use
- 05 Mar 2014 New trial record